Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 18, 2022

SELL
$2.85 - $3.73 $206,625 - $270,425
-72,500 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.24 - $5.18 $19,440 - $31,080
6,000 Added 9.02%
72,500 $244,000
Q3 2021

Nov 15, 2021

BUY
$3.94 - $5.84 $3,940 - $5,840
1,000 Added 1.53%
66,500 $342,000
Q2 2021

Aug 16, 2021

BUY
$4.26 - $6.5 $41,535 - $63,375
9,750 Added 17.49%
65,500 $293,000
Q1 2021

May 17, 2021

BUY
$5.03 - $8.8 $280,422 - $490,600
55,750 New
55,750 $355,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.